3.1200
-0.1300
(-4.00%)
At close: January 10 at 4:00:01 PM EST
3.2400
+0.12
+(3.85%)
After hours: January 10 at 6:37:04 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,881.3160
2,807.8850
10,000.0000
--
--
Operating Expense
25,108.3900
33,747.7650
41,385.4880
39,068.5120
27,402.2570
Operating Income
-23,234.7480
-30,939.8800
-31,385.4880
-39,068.5120
-27,402.2570
Other Income Expense
19,629.9850
778.4890
437.7500
372.4070
1.5140
Pretax Income
-3,604.7630
-30,161.3910
-30,947.7380
-38,696.1050
-27,400.7430
Net Income Common Stockholders
-3,604.7630
-30,161.3910
-30,947.7380
-38,696.1050
-27,407.6060
Diluted NI Available to Com Stockholders
-3,604.7630
-30,161.3910
-30,947.7380
-38,696.1050
-27,407.6060
Basic EPS
-0.58
-4.20
-4.44
-7.56
-10.92
Diluted EPS
-0.58
-4.20
-4.44
-7.56
-10.92
Basic Average Shares
8,316.6010
7,275.3080
7,047.6500
5,096.1790
2,507.6220
Diluted Average Shares
8,336.6670
7,275.3080
7,047.6500
5,096.1790
2,507.6220
Total Operating Income as Reported
-23,234.7480
-30,939.8800
-31,385.4880
-39,068.5120
-27,402.2570
Total Expenses
25,116.0640
33,747.7650
41,385.4880
39,068.5120
27,402.2570
Net Income from Continuing & Discontinued Operation
-3,604.7630
-30,161.3910
-30,947.7380
-38,696.1050
-27,400.7430
Normalized Income
-23,984.1390
-30,161.3910
-30,947.7380
-39,065.9920
-27,400.7430
EBIT
-23,234.7480
-30,939.8800
-31,385.4880
-39,068.5120
-27,402.2570
EBITDA
-23,188.8110
-30,901.5170
-31,361.2860
-39,042.0990
-27,359.0300
Reconciled Depreciation
45.9370
38.3630
24.2020
26.4130
43.2270
Net Income from Continuing Operation Net Minority Interest
-3,604.7630
-30,161.3910
-30,947.7380
-38,696.1050
-27,400.7430
Total Unusual Items Excluding Goodwill
20,379.3760
--
--
369.8870
--
Total Unusual Items
20,379.3760
--
--
369.8870
--
Normalized EBITDA
-43,568.1870
-30,901.5170
-31,361.2860
-39,411.9860
-27,359.0300
12/31/2020 - 4/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XBIO Xenetic Biosciences, Inc.
3.8600
-4.22%
VTVT vTv Therapeutics Inc.
13.80
-2.06%
ALRN Aileron Therapeutics, Inc.
2.1100
+9.33%
CRIS Curis, Inc.
3.3900
-2.02%
PXMD PaxMedica, Inc.
0.0580
-10.77%
ACHV Achieve Life Sciences, Inc.
3.3800
-3.98%
RLMD Relmada Therapeutics, Inc.
0.4124
-8.76%
IRD Opus Genetics, Inc.
1.4200
-2.07%
COCP Cocrystal Pharma, Inc.
2.2100
-7.14%
TOVX Theriva Biologics, Inc.
1.4500
-1.36%